Adverse Drug Reaction
Patients with interferon-induced Graves disease fare better than others
Published in Hepatitis Weekly, July 4th, 2005
"An association between Graves disease (GD) and chronic hepatitis C (C-HC) has been observed both in the presence and the absence of recombinant interferon-alpha (rIFN-alpha) treatment," scientists in Italy report.
"rIFN-alpha-induced GD is characterized by suppressed thyroid-stimulating hormone levels; normal or elevated free triiodothyronine (FT3) and free thyroxine (FT4) values; the presence of thyroid peroxidase antibodies, antithyroglobulin antibodies, and thyroid receptor antibodies; and high iodine thyroid uptake. In contrast, GD developed during C-HC without rIFN-alpha...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-07-04)
More Articles from Hepatitis Weekly
- Diagnostics
IgM anti-hepatitis C virus titers divulge the threat of acute hepatitis - Hepatocellular Carcinoma
Murine liver tumors respond to combined suicide-cytokine gene therapy - Vaccine Development
Immunostimulatory adjuvant may be key to hepatitis C vaccine efficacy - Vaccine Development
Oligonucleotide prototype boosts immunological response to hepatitis B vaccine - Addiction Medicine
MELD scores are superior predictors of alcoholic hepatitis related mortality - Antiviral Therapy
Combination therapy produces a sustained response in HCV cirrhosis - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
